{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:55:30Z","timestamp":1761490530903,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T00:00:00Z","timestamp":1525737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41409-018-0206-5","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:41:31Z","timestamp":1525254091000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease"],"prefix":"10.1038","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8339-8899","authenticated-orcid":false,"given":"Marietta","family":"Nygaard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonny","family":"Karlsmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels Smedegaard","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Marie","family":"Schj\u00f8dt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8ren Lykke","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lone Smidstrup","family":"Friis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian Thomas","family":"Kornblit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Sengel\u00f8v","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"206_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/bbmt.2003.50003","volume":"9","author":"M Arora","year":"2003","unstructured":"Arora M, Burns LJ, Davies SM, MacMillan ML, Defor TE, Miller WJ, et al. Chronic graft-versus-host disease: a prospective cohort study. Biol Blood Marrow Transplant. 2003;9:38\u201345.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.bbmt.2014.10.021","volume":"21","author":"S Arai","year":"2015","unstructured":"Arai S, Arora M, Wang T, Spellman SR, He W, Couriel DR, et al. Increasing incidence of chronic graft-versus-host disease inallogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research. Biol Blood Marrow Transplant. 2015;21:266\u201374.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.bbmt.2008.09.017","volume":"14","author":"MED Flowers","year":"2008","unstructured":"Flowers MED, Storer B, Carpenter P, Rezvani AR, Vigorito AC, Campregher PV, et al. Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008;14:1380\u20134.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR4","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1182\/blood-2014-03-563544","volume":"124","author":"Y Inamoto","year":"2014","unstructured":"Inamoto Y, Flowers MED, Sandmaier BM, Aki SZ, Carpenter PA, Lee SJ, et al. Failure-free survival after initial systemic treatment of chronic graft-versus-host disease. Blood. 2014;124:1363\u201371.","journal-title":"Blood"},{"key":"206_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbmt.2010.05.011","volume":"17","author":"D Wolff","year":"2011","unstructured":"Wolff D, Schleuning M, von Harsdorf S, Bacher U, Gerbitz A, Stadler M, et al. Consensus conference on clinical practice in chronic GVHD: second-line treatment of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2011;17:1\u201317.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.5045\/kjh.2011.46.3.153","volume":"46","author":"PJ Martin","year":"2011","unstructured":"Martin PJ, Inamoto Y, Carpenter PA, Lee SJ, Flowers MED. Treatment of chronic graft-versus-host disease: past, present and future. Korean J Hematol. 2011;46:153\u201363.","journal-title":"Korean J Hematol"},{"key":"206_CR7","first-page":"374","volume":"124","author":"G Soci\u00e9","year":"2014","unstructured":"Soci\u00e9 G, Ritz J. Current issues in chronic graft-versus-host disease. Adv Hematop Cell Transplant. 2014;124:374\u201384.","journal-title":"Adv Hematop Cell Transplant"},{"key":"206_CR8","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1182\/blood-2002-11-3351","volume":"102","author":"ED Seaton","year":"2003","unstructured":"Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood. 2003;102:1217\u201323.","journal-title":"Blood"},{"key":"206_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1046\/j.1365-2141.2003.04401.x","volume":"122","author":"C Messina","year":"2003","unstructured":"Messina C, Locatelli F, Lanino E, Uderzo C, Zacchello G, Cesaro S, et al. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol. 2003;122:118\u201327.","journal-title":"Br J Haematol"},{"key":"206_CR10","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1182\/blood-2005-09-3907","volume":"107","author":"DR Couriel","year":"2006","unstructured":"Couriel DR, Hosing C, Saliba R, Shpall EJ, Anderlini P, Rhodes B, et al. Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood. 2006;107:3074\u201380.","journal-title":"Blood"},{"key":"206_CR11","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1182\/blood-2008-03-141481","volume":"112","author":"MED Flowers","year":"2008","unstructured":"Flowers MED, Apperley JF, van Besien K, Elmaagacli A, Grigg A, Reddy V, et al. A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease. Blood. 2008;112:2667\u201374.","journal-title":"Blood"},{"key":"206_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/j.1744-9987.2007.00421.x","volume":"11","author":"P Perseghin","year":"2007","unstructured":"Perseghin P, Galimberti S, Balduzzi A, Bonanomi S, Baldini V, Rovelli A, et al. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect? Ther Apher Dial. 2007;11:85\u201393.","journal-title":"Ther Apher Dial"},{"key":"206_CR13","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bbmt.2009.06.007","volume":"15","author":"MH Jagasia","year":"2009","unstructured":"Jagasia MH, Savani BN, Stricklin G, Engelhardt B, Kassim A, Dixon S, et al. Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP). Biol Blood Marrow Transplant. 2009;15:1288\u201395.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR14","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1537-2995.2009.02577.x","volume":"50","author":"C Perotti","year":"2010","unstructured":"Perotti C, Del Fante C, Tinelli C, Viarengo G, Scudeller L, Zecca M, et al. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients. Transfusion. 2010;50:1359\u201369.","journal-title":"Transfusion"},{"key":"206_CR15","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.bbmt.2011.05.004","volume":"17","author":"HT Greinix","year":"2011","unstructured":"Greinix HT, van Besien K, Elmaagacli AH, Hillen U, Grigg A, Knobler R, et al. Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study. Biol Blood Marrow Transplant. 2011;17:1775\u201382.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/bmt.2011.186","volume":"47","author":"FL Dignan","year":"2012","unstructured":"Dignan FL, Greenblatt D, Cox M, Cavenagh J, Oakervee H, Apperley JF, et al. Efficacy of bimonthly extracorporeal photopheresis in refractory chronic mucocutaneous GVHD. Bone Marrow Transplant. 2012;47:824\u201330.","journal-title":"Bone Marrow Transplant"},{"key":"206_CR17","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1111\/j.1537-2995.2011.03542.x","volume":"52","author":"C Fante Del","year":"2012","unstructured":"Del Fante C, Scudeller L, Viarengo G, Bernasconi P, Perotti C. Response and survival of patients with chronic graft-versus-host disease treated by extracorporeal photochemotherapy: a retrospective study according to classical and National Institutes of Health classifications. Transfusion. 2012;52:2007\u201315.","journal-title":"Transfusion"},{"key":"206_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/bmt.2014.21","volume":"49","author":"FL Dignan","year":"2014","unstructured":"Dignan FL, Aguilar S, Scarisbrick JJ, Shaw BE, Potter MN, Cavenagh J, et al. Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD. Bone Marrow Transplant. 2014;49:704\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"206_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/bmt.2012.156","volume":"48","author":"AH Hautmann","year":"2013","unstructured":"Hautmann AH, Wolff D, Hahn J, Edinger M, Schirmer N, Ammer J, et al. Extracorporeal photopheresis in 62 patients with acute and chronic GVHD: results of treatment with the COBE spectra system. Bone Marrow Transplant. 2013;48:439\u201345.","journal-title":"Bone Marrow Transplant"},{"key":"206_CR20","doi-asserted-by":"publisher","unstructured":"Berger M, Albiani R, Sini B, Fagioli F. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study. Transfusion 2014. https:\/\/doi.org\/10.1111\/trf.12900 .","DOI":"10.1111\/trf.12900"},{"key":"206_CR21","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1097\/TP.0000000000001466","volume":"100","author":"M Malagola","year":"2016","unstructured":"Malagola M, Cancelli V, Skert C, Leali PF, Ferrari E, Tiburzi A, et al. Extracorporeal photopheresis for treatment of acute and chronic graft versus host disease. Transplantation. 2016;100:e147\u2013e155.","journal-title":"Transplantation"},{"key":"206_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00262-014-1578-z","volume":"63","author":"Oslash Bruserud","year":"2014","unstructured":"Bruserud \u00d8, Tvedt THA, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tj\u00f8nnfjord GE, et al. Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies. Cancer Immunol Immunother. 2014;63:757\u201377.","journal-title":"Cancer Immunol Immunother"},{"key":"206_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.5045\/br.2014.49.2.100","volume":"49","author":"MI Malik","year":"2014","unstructured":"Malik MI, Litzow M, Hogan W, Patnaik M, Murad MH, Prokop LJ, et al. Extracorporeal photopheresis for chronic graft-versus-host disease: a systematic review and meta-analysis. Blood Res. 2014;49:100\u20136.","journal-title":"Blood Res"},{"key":"206_CR24","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2014-08-551994","volume":"125","author":"MED Flowers","year":"2015","unstructured":"Flowers MED, Martin PJ. How we treat chronic graft-versus-host disease. Blood. 2015;125:606\u201315.","journal-title":"Blood"},{"key":"206_CR25","doi-asserted-by":"crossref","unstructured":"Martin PJ, Storer BE, Inamoto Y, Flowers MED, Carpenter PA, Pidala J, et al. An endpoint associated with clinical benefit after initial treatment for chronic graft-versus-host disease. Blood 2017; 130: 360\u2013367.","DOI":"10.1182\/blood-2017-03-775767"},{"key":"206_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","volume":"21","author":"MH Jagasia","year":"2015","unstructured":"Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2015;21:389\u2013401.","journal-title":"Biol Blood Marrow Transplant"},{"key":"206_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.1365-2133.2007.08415.x","volume":"158","author":"JJ Scarisbrick","year":"2008","unstructured":"Scarisbrick JJ, Taylor P, Holtick U, Makar Y, Douglas K, Berlin G, et al. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease. Br J Dermatol. 2008;158:659\u201378.","journal-title":"Br J Dermatol"},{"key":"206_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/bjh.14537","volume":"177","author":"A Alfred","year":"2017","unstructured":"Alfred A, Taylor PC, Dignan F, El-Ghariani K, Griffin J, Gennery AR, et al. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society. Br J Haematol. 2017;177:287\u2013310.","journal-title":"Br J Haematol"},{"key":"206_CR29","doi-asserted-by":"publisher","unstructured":"Abu-Dalle I, Reljic T, Nishihori T, Antar A, Bazarbachi A, Djulbegovic B, et al. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies. Biol Blood Marrow Transplant. 2014. https:\/\/doi.org\/10.1016\/j.bbmt.2014.05.017 .","DOI":"10.1016\/j.bbmt.2014.05.017"},{"key":"206_CR30","doi-asserted-by":"publisher","unstructured":"Curtis LM, Pirsl F, Steinberg SM, Mitchell SA, Baird K, Cowen EW, et al. Predictors for permanent discontinuation of systemic immunosuppression in severely affected chronic graft-versus-host disease patients. Biol Blood Marrow Transplant. 2017;274. https:\/\/doi.org\/10.1016\/j.bbmt.2017.08.005 .","DOI":"10.1016\/j.bbmt.2017.08.005"},{"key":"206_CR31","first-page":"1096","volume":"90","author":"F Garban","year":"2005","unstructured":"Garban F, Drillat P, Makowski C, Jacob M-C, Richard M-J, Favrot M, et al. Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses. Haematologica. 2005;90:1096\u2013101.","journal-title":"Haematologica"},{"key":"206_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/jca.20084","volume":"21","author":"E Bisaccia","year":"2006","unstructured":"Bisaccia E, Palangio M, Gonzalez J, Adler KR, Scarborough R, Goldberg SL, et al. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy. J Clin Apher. 2006;21:181\u20137.","journal-title":"J Clin Apher"},{"key":"206_CR33","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1111\/j.1537-2995.2007.01469.x","volume":"47","author":"J Kanold","year":"2007","unstructured":"Kanold J, Merlin E, Halle P, Paillard C, Marabelle A, Rapatel C, et al. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature. Transfusion. 2007;47:2276\u201389.","journal-title":"Transfusion"},{"key":"206_CR34","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1182\/blood.V92.9.3098","volume":"92","author":"HT Greinix","year":"1998","unstructured":"Greinix HT, Volc-Platzer B, Rabitsch W, Gmeinhart B, Guevara-Pineda C, Kalhs P, et al. Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease. Blood. 1998;92:3098\u2013104.","journal-title":"Blood"},{"key":"206_CR35","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/sj.bmt.1701733","volume":"23","author":"FJ Child","year":"1999","unstructured":"Child FJ, Ratnavel R, Watkins P, Samson D, Apperley J, Ball J, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant. 1999;23:881\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"206_CR36","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1046\/j.1537-2995.2001.41101299.x","volume":"41","author":"L Salvaneschi","year":"2001","unstructured":"Salvaneschi L, Perotti C, Zecca M, Bernuzzi S, Viarengo G, Giorgiani G, et al. Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion. 2001;41:1299\u2013305.","journal-title":"Transfusion"},{"key":"206_CR37","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.bmt.1704984","volume":"35","author":"FM Foss","year":"2005","unstructured":"Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, et al. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant. 2005;35:1187\u201393.","journal-title":"Bone Marrow Transplant"},{"key":"206_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1177\/112067210701700615","volume":"17","author":"E Motolese","year":"2007","unstructured":"Motolese E, Rubegni P, Poggiali S, Motolese PA, Marotta G, Russo L, et al. Ocular manifestations of chronic graft-versus-host disease in patients treated with extracorporeal photochemotherapy. Eur J Ophthalmol. 2007;17:961\u20139.","journal-title":"Eur J Ophthalmol"},{"key":"206_CR39","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.transproceed.2013.07.053","volume":"45","author":"M Ussowicz","year":"2013","unstructured":"Ussowicz M, Musia\u0142 J, Mielcarek M, Tomaszewska A, Nasi\u0142owska-Adamska B, Ka\u0142wak K, et al. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Transplant Proc. 2013;45:3375\u201380.","journal-title":"Transplant Proc"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0206-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0206-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:12:10Z","timestamp":1684617130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0206-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,8]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0206-5","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2018,5,8]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MN has received travel grant for conference participation and speakers fee from Therakos (Mallinckrodt). The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}